These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 9771479)
21. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306 [TBL] [Abstract][Full Text] [Related]
22. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Kato Y; Hirano T; Yoshida K; Yashima K; Akimoto S; Tsuji K; Ohira T; Tsuboi M; Ikeda N; Ebihara Y; Kato H Lung Cancer; 2005 Jun; 48(3):323-30. PubMed ID: 15893000 [TBL] [Abstract][Full Text] [Related]
23. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369 [TBL] [Abstract][Full Text] [Related]
24. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. Bagutti C; Speight PM; Watt FM J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134 [TBL] [Abstract][Full Text] [Related]
25. Beta- and gamma-catenin expression in oral squamous cell carcinomas. Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318 [TBL] [Abstract][Full Text] [Related]
26. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Fujioka T; Takebayashi Y; Kihana T; Kusanagi Y; Hamada K; Ochi H; Uchida T; Fukumoto M; Ito M Oncol Rep; 2001; 8(2):249-55. PubMed ID: 11182035 [TBL] [Abstract][Full Text] [Related]
27. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301 [TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome. Ramburan A; Hadley GP; Govender D Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007 [TBL] [Abstract][Full Text] [Related]
29. Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Hao X; Palazzo JP; Ilyas M; Tomlinson I; Talbot IC Anticancer Res; 1997; 17(3C):2241-7. PubMed ID: 9216695 [TBL] [Abstract][Full Text] [Related]
30. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence. Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807 [TBL] [Abstract][Full Text] [Related]
31. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
32. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552 [TBL] [Abstract][Full Text] [Related]
33. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141 [TBL] [Abstract][Full Text] [Related]
34. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients. El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065 [TBL] [Abstract][Full Text] [Related]
35. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion. Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308 [TBL] [Abstract][Full Text] [Related]
36. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137 [TBL] [Abstract][Full Text] [Related]
37. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers]. Yang JF; Chen SL; Liu ZH; Zhang Y Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915 [TBL] [Abstract][Full Text] [Related]
38. Altered E-cadherin/beta-catenin expression in oral squamous carcinoma with and without nodal metastasis. Mahomed F; Altini M; Meer S Oral Dis; 2007 Jul; 13(4):386-92. PubMed ID: 17577324 [TBL] [Abstract][Full Text] [Related]
39. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365 [TBL] [Abstract][Full Text] [Related]
40. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex. Rocha AS; Soares P; Machado JC; Máximo V; Fonseca E; Franssila K; Sobrinho-Simões M Virchows Arch; 2002 May; 440(5):498-504. PubMed ID: 12021924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]